Another report suggests that MCL-1 expression (but not BCL-2 or BCL-XL) is upregulated in both chemo-resistant HNSCC lines and chemo-resistant tumors compared with chemo-sensitive counterparts [41]. This evidence concerns the gene BCL2 and head and neck squamous cell carcinoma.